FDA Inspection
Reproductive Medicine InstituteReproductive Medicine Institute – FDA Inspection, Aug 17, 2018
Record Details
This FDA Inspection record concerns Reproductive Medicine Institute, with an inspection on August 17, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · d83594bf-b9d2-4028-81e6-9bd4035acefd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1062789
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.47(a)Design of procedures to ensure compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Reproductive Medicine Institute
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 17, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Reproductive Medicine Institute
- FDA Inspection 1216323 - 2023-08-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.